Prothena Corporation plc

Available to platforms
R StocksTrader
Prothena Corporation is a company with experience in studying diseases related to protein metabolism dysregulation, with its drugs in the final stages of clinical trials. The portfolio includes a number of experimental drugs capable of altering the course of rare severe neurodegenerative diseases and neuropathies caused by amyloid infiltration of peripheral nerves. The company is developing several drugs for the treatment of Alzheimer's disease, including in collaboration with Bristol-Myers Squibb, as well as for Parkinson's disease and others.

Prothena Corporation plc (PRTA) on the NASDAQ Exchange

Company overview

Prothena Corporation plc is a publicly listed company from USA with shares traded on NASDAQ under the ticker PRTA. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for PRTA are bid 10.29 USD and ask 10.43 USD.

Use the chart to review recent momentum, identify key price areas, and track how Prothena Corporation plc is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add PRTA to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NASDAQ
  • Company: Prothena Corporation plc
  • Ticker: PRTA
  • Country: USA
  • Bid10.29 USD
  • Ask10.43 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of PRTA does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Prothena Corporation plc (PRTA) in R StocksTrader. Create and verify your profile, fund the account, search for PRTA, and choose the instrument type available to you. Add PRTA to your Watchlist to track moves and manage open positions throughout 2025.

PRTA trades on NASDAQ and is issued by Prothena Corporation plc. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for PRTA match your plan.

Quotes update automatically in real time. Current levels for PRTA are bid 10.29 USD and ask 10.43 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track PRTA in R StocksTrader and adjust your approach as market conditions change in 2025.